Der Katzenurin-Entferner von ZOOPRINZ überzeugt durch seine natürlichen Inhaltsstoffe und seine vielseitige Wirkung. Sowohl ...

How to diagnose 'persistent infection' that leads to gastritis, gastric ulcers, and gastric cancer —Helicobacter pylori ...

Oct 2 (Reuters) - An advisory panel to the US Food and Drug Administration handed Grail's (GRAL.O), opens new tab Galleri blood test a milestone win last week, saying the early cancer detection test's ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...

A divided Food and Drug Administration panel narrowly backed a controversial blood-based cancer test Wednesday, a step forward for an emerging field of cancer screenings that could offer less invasive ...

A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is ...

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers early. By Nina Agrawal An advisory committee to the Food and Drug ...

Matthew Herper covers medical innovation — both its promise and its perils. A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced ...

The FDA cleared the Elecsys Phospho-Tau (217P) Plasma blood test, which Roche and Lilly say is the single-biomarker blood test designed to test for the likelihood of amyloid pathology, a brain symptom ...